S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   421.77 (-0.39%)
AAPL   165.45 (-0.95%)
MSFT   402.79 (-0.37%)
META   494.61 (-1.43%)
GOOGL   154.86 (-0.74%)
AMZN   177.91 (-0.73%)
TSLA   148.66 (-0.85%)
NVDA   839.38 (-0.87%)
AMD   153.36 (-1.11%)
NIO   3.86 (-3.50%)
BABA   68.71 (-0.25%)
T   16.39 (+0.37%)
F   12.18 (+1.00%)
MU   109.70 (-1.99%)
GE   152.93 (+-0.01%)
CGC   8.22 (+4.98%)
DIS   112.24 (-0.17%)
AMC   3.07 (+5.14%)
PFE   25.45 (+0.24%)
PYPL   62.09 (-0.02%)
XOM   120.08 (+1.32%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
$120,000.00
$120,000.00
$120,000.00
$120,000.00
N/A0.01N/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$106.64
+0.6%
$109.53
$77.56
$116.04
$25.94B0.682.22 million shs80,083 shs
Herbalife Ltd. stock logo
HLF
Herbalife
$8.78
+2.2%
$8.96
$6.68
$19.48
$876.16M1.222.24 million shs71,156 shs
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$12.83
+1.0%
$13.20
$11.84
$41.50
$634.06M1.11759,971 shs31,674 shs
PetIQ, Inc. stock logo
PETQ
PetIQ
$16.14
+0.7%
$17.49
$11.26
$22.98
$475M1.64285,063 shs12,262 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
-0.49%-0.38%-6.07%+0.50%+34.19%
Herbalife Ltd. stock logo
HLF
Herbalife
+4.43%+3.55%-1.32%-30.77%-40.64%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
+2.71%+3.67%+0.67%-26.96%-68.93%
PetIQ, Inc. stock logo
PETQ
PetIQ
+0.63%-7.39%-6.86%-11.44%+41.73%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.2549 of 5 stars
1.33.03.33.62.71.73.1
Herbalife Ltd. stock logo
HLF
Herbalife
4.1191 of 5 stars
1.93.00.03.93.11.73.1
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
4.7386 of 5 stars
3.05.01.71.42.32.53.1
PetIQ, Inc. stock logo
PETQ
PetIQ
3.2691 of 5 stars
3.53.00.00.03.31.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-3.35% Downside
Herbalife Ltd. stock logo
HLF
Herbalife
1.80
Reduce$10.5019.59% Upside
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.00
Hold$23.6784.46% Upside
PetIQ, Inc. stock logo
PETQ
PetIQ
3.00
Buy$29.0079.68% Upside

Current Analyst Ratings

Latest HLF, NUS, BTCA, PETQ, and CAH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/25/2024
Herbalife Ltd. stock logo
HLF
Herbalife
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$11.00 ➝ $9.50
3/21/2024
Herbalife Ltd. stock logo
HLF
Herbalife
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$10.00 ➝ $8.00
3/21/2024
Herbalife Ltd. stock logo
HLF
Herbalife
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $10.00
3/19/2024
PetIQ, Inc. stock logo
PETQ
PetIQ
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$24.00 ➝ $28.00
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$125.00
2/16/2024
Herbalife Ltd. stock logo
HLF
Herbalife
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$14.00 ➝ $12.00
2/9/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
2/5/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$122.00 ➝ $125.00
1/29/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$114.00 ➝ $122.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.13$8.69 per share12.27($11.20) per share-9.52
Herbalife Ltd. stock logo
HLF
Herbalife
$5.06B0.17$3.61 per share2.43($10.70) per share-0.82
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$1.97B0.32$3.42 per share3.75$16.60 per share0.77
PetIQ, Inc. stock logo
PETQ
PetIQ
$1.10B0.43$2.72 per share5.94$7.58 per share2.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/A0.00N/AN/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5441.9813.261.030.30%-57.44%3.89%5/2/2024 (Confirmed)
Herbalife Ltd. stock logo
HLF
Herbalife
$142.20M$1.426.183.16N/A2.81%-19.56%8.07%5/1/2024 (Confirmed)
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$8.60M$0.1871.288.61N/A0.44%10.73%5.03%5/8/2024 (Confirmed)
PetIQ, Inc. stock logo
PETQ
PetIQ
$2.13M$0.06269.0413.23N/A0.19%11.72%3.10%5/14/2024 (Estimated)

Latest HLF, NUS, BTCA, PETQ, and CAH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.05N/A-$0.05N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
5/1/2024N/A
Herbalife Ltd. stock logo
HLF
Herbalife
$0.37N/A-$0.37N/AN/AN/A  
2/28/2024Q4 2023
PetIQ, Inc. stock logo
PETQ
PetIQ
-$0.38-$0.16+$0.22$0.28$189.70 million$219.93 million
2/14/2024Q4 2023
Herbalife Ltd. stock logo
HLF
Herbalife
$0.38$0.28-$0.10$0.46$1.19 billion$1.20 billion    
2/14/2024Q4 2023
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.29$0.37+$0.08$0.59$479.35 million$488.64 million
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.88%+1.00%78.74%27 Years
Herbalife Ltd. stock logo
HLF
Herbalife
N/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.241.87%+1.32%133.34%N/A
PetIQ, Inc. stock logo
PETQ
PetIQ
N/AN/AN/AN/AN/A

Latest HLF, NUS, BTCA, PETQ, and CAH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
2/14/2024
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
quarterly$0.061.7%2/23/20242/26/20243/6/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
Herbalife Ltd. stock logo
HLF
Herbalife
N/A
1.10
0.70
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.58
2.13
1.28
PetIQ, Inc. stock logo
PETQ
PetIQ
1.97
2.27
1.43

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Herbalife Ltd. stock logo
HLF
Herbalife
N/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
82.84%
PetIQ, Inc. stock logo
PETQ
PetIQ
94.99%

Insider Ownership

CompanyInsider Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
41.40%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
Herbalife Ltd. stock logo
HLF
Herbalife
0.94%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.00%
PetIQ, Inc. stock logo
PETQ
PetIQ
9.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
126N/AN/ANot Optionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
Herbalife Ltd. stock logo
HLF
Herbalife
9,20099.79 million98.85 millionOptionable
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
3,70049.42 million48.43 millionOptionable
PetIQ, Inc. stock logo
PETQ
PetIQ
1,93329.43 million26.69 millionOptionable

HLF, NUS, BTCA, PETQ, and CAH Headlines

SourceHeadline
Unleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big ReturnsUnleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big Returns
investorplace.com - April 18 at 6:30 AM
Wall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a BetWall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a Bet
zacks.com - April 15 at 10:55 AM
White Brook Capital Partners Q1 2024 CommentaryWhite Brook Capital Partners Q1 2024 Commentary
seekingalpha.com - April 13 at 1:07 PM
Vanguard Group Inc. Buys 226,718 Shares of PetIQ, Inc. (NASDAQ:PETQ)Vanguard Group Inc. Buys 226,718 Shares of PetIQ, Inc. (NASDAQ:PETQ)
marketbeat.com - April 11 at 4:11 AM
PetIQ, Inc. (PETQ) Is a Trending Stock: Facts to Know Before Betting on ItPetIQ, Inc. (PETQ) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com - April 10 at 10:00 AM
Theres Been No Shortage Of Growth Recently For PetIQs (NASDAQ:PETQ) Returns On CapitalThere's Been No Shortage Of Growth Recently For PetIQ's (NASDAQ:PETQ) Returns On Capital
finance.yahoo.com - April 9 at 6:11 PM
PetIQ (PETQ) Dips More Than Broader Market: What You Should KnowPetIQ (PETQ) Dips More Than Broader Market: What You Should Know
finance.yahoo.com - April 8 at 8:55 PM
Should Value Investors Buy PetIQ (PETQ) Stock?Should Value Investors Buy PetIQ (PETQ) Stock?
zacks.com - April 8 at 10:46 AM
Assenagon Asset Management S.A. Decreases Stake in PetIQ, Inc. (NASDAQ:PETQ)Assenagon Asset Management S.A. Decreases Stake in PetIQ, Inc. (NASDAQ:PETQ)
marketbeat.com - March 31 at 4:42 AM
Wall Street Analysts Believe PetIQ (PETQ) Could Rally 58.64%: Heres is How to TradeWall Street Analysts Believe PetIQ (PETQ) Could Rally 58.64%: Here's is How to Trade
zacks.com - March 29 at 10:56 AM
Are Investors Undervaluing PetIQ (PETQ) Right Now?Are Investors Undervaluing PetIQ (PETQ) Right Now?
zacks.com - March 21 at 10:46 AM
PetIQ (NASDAQ:PETQ) Shares Gap Up  After Analyst UpgradePetIQ (NASDAQ:PETQ) Shares Gap Up After Analyst Upgrade
marketbeat.com - March 19 at 11:48 AM
PetIQ (NASDAQ:PETQ) Price Target Increased to $28.00 by Analysts at Jefferies Financial GroupPetIQ (NASDAQ:PETQ) Price Target Increased to $28.00 by Analysts at Jefferies Financial Group
marketbeat.com - March 19 at 8:47 AM
PetIQ (PETQ) Broadens Minties Line With Large Dogs Dental TreatsPetIQ (PETQ) Broadens Minties Line With Large Dogs Dental Treats
zacks.com - March 18 at 10:31 AM
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized DogsPetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized Dogs
globenewswire.com - March 14 at 9:00 AM
PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support ResourcesPetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources
globenewswire.com - March 7 at 10:00 AM
PetIQ Full Year 2023 Earnings: EPS: US$0.073 (vs US$1.65 loss in FY 2022)PetIQ Full Year 2023 Earnings: EPS: US$0.073 (vs US$1.65 loss in FY 2022)
finance.yahoo.com - March 1 at 10:44 AM
PetIQ, Inc. (NASDAQ:PETQ) Q4 2023 Earnings Call TranscriptPetIQ, Inc. (NASDAQ:PETQ) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 1:30 PM
PetIQ, Inc. 2023 Q4 - Results - Earnings Call PresentationPetIQ, Inc. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 29 at 12:07 AM
Heres what to expect from PetIQ As earningsHere's what to expect from PetIQ A's earnings
markets.businessinsider.com - February 28 at 8:51 PM
PetIQ: Q4 Earnings SnapshotPetIQ: Q4 Earnings Snapshot
sfgate.com - February 28 at 8:51 PM
PetIQ Inc (PETQ) Reports Strong Growth in 2023 with Record Net Sales and Cash FlowPetIQ Inc (PETQ) Reports Strong Growth in 2023 with Record Net Sales and Cash Flow
finance.yahoo.com - February 28 at 8:51 PM
PetIQ (PETQ) Reports Q4 Loss, Tops Revenue EstimatesPetIQ (PETQ) Reports Q4 Loss, Tops Revenue Estimates
zacks.com - February 28 at 7:01 PM
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsPetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - February 28 at 4:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bactolac Pharmaceutical logo

Bactolac Pharmaceutical

OTCMKTS:BTCA
Bactolac Pharmaceutical, Inc. engages in the research, development and commercialization of vitamins and neutraceuticals. It offers nutritional supplements and shake powders, resveratrol, probiotics, multivitamins, antioxidant products, sports and hormone supplements, and weight loss and detoxification drugs. The company was founded by Pailla Malla Reddy in 1995 and is headquartered in Hauppauge, NY.
Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Herbalife logo

Herbalife

NYSE:HLF
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items. The company also provides weight management products, including meal replacement products, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. In addition, it offers literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. The company sells its products through sales representatives, independent service providers, and company-operated retail platforms. Herbalife Ltd. was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. The company was founded in 1980 and is headquartered in Los Angeles, California.
Nu Skin Enterprises logo

Nu Skin Enterprises

NYSE:NUS
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
PetIQ logo

PetIQ

NASDAQ:PETQ
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.